Common confounder could skew biologic trials

The outcomes of many clinical trials involving the use of biologics in rheumatoid arthritis could be skewed because they overlook the socio-economic status of patients, researchers say. Writing in a letter published in Rheumatology the team of researchers led by Dr Helen Benham from the University of Queensland said it was well known that lower ...

Already a member?

Login to keep reading.

© 2021 the limbic